Ytd revenues increase 87% to $1.7 million Quarterly revenues increase 166% to $734,000 MONTREAL, Nov. 1 /PRNewswire-FirstCall/ -- LMS Medical Systems (TSX: LMZ, AMEX: LMZ), a healthcare technology company and developer of the CALM(R) clinical information system and risk management software tools for obstetrics, today reported revenues for the second quarter of fiscal 2008 ended September 30, 2007. All amounts are in Canadian dollars. Revenues in Q2 2008 increased by 166% to $735,000 from $276,000 in Q2 2007. Our recurring maintenance and technical revenues continue to grow from our installed client base and increased by 36% to $703,000 from $517,000 for the comparative six-month period. Year-to-date revenues increased by 87% to $1.7 million from $907,000. In conjunction with seasonally stronger winter and spring quarters (Q3 and Q4) and corporate streamlining of operations, management anticipates reaching a cash flow break even at the end of the current fiscal year. Complete results for the second quarter along with Management's Discussion and Analysis will be released in normal course on or about November 14th and will be available in Canada at http://www.sedar.com/, in the United States at http://www.sec.gov/ and at http://www.lmsmedical.com/. ABOUT LMS LMS is a leader in the application of advanced mathematical modeling and neural networks for medical use. The LMS CALM(TM) Suite provides physicians, nursing staff, risk managers and hospital administrators with clinical information systems and risk management tools designed to improve outcomes and patient care for mothers and their infants during childbirth. Except for historical information contained herein, the matters discussed in this news release are forward-looking statements. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed implied by the forward-looking statements including, but without limitation, economic conditions in general and in the healthcare market, the demand for and market for our products in domestic and international markets, our current dependence on the CALM product suite, the challenges associated with developing new products and obtaining regulatory approvals if necessary, research and development activities, the uncertainty of acceptance of our products by the medical community, the lengthy sales cycle for our products, third party reimbursement, competition in our markets, including the potential introduction of competitive products by others, our dependence on our distributors, physician training, enforceability and the costs of enforcement of our patents, potential infringements of our patents and the other factors set forth from time to time in the Company's filings with the United States Securities and Exchange Commission and with the Canadian Securities Commissions. The Company has no intention of or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. DATASOURCE: LMS MEDICAL SYSTEMS INC. CONTACT: Yves Grou, Chief Financial Officer, LMS Medical Systems Inc., (514) 488-3461 Ext. 238, Fax: (514) 488-1880, , http://www.lmsmedical.com/

Copyright